Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.80
Delayed Data
As of Feb 12
 +0.01 / +1.27%
Today’s Change
0.71
Today|||52-Week Range
5.55
-34.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2010
Quarter 1
2011
Quarter 2
2011
Quarter 3
2015
Revenue and IncomeNet Revenues45.0K37.0K22.0K2.4M
 
 
 
 
 
Cost of Goods Sold158.0K124.0K65.0K2.2M
 
 
 
 
 
 
Operating ExpensesGross Income-113.0K-87.0K-43.0K263.0K
 
 
 
 
 
General Expenses3.4M2.5M3.2M4.1M
 
 
 
 
 
Research And Development1.2M1.0M1.3M586.0K
 
 
 
 
 
Total Operating Expenses3.6M2.6M3.2M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-2.6M-3.2M-3.9M
 
 
 
 
 
Interest Expense On Debt28.0K----0.00
 
 
Other Expenses0.00822.0K421.0K-47.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-1.8M-2.8M-3.9M
 
 
 
 
 
Income Taxes0.000.000.00-5.0K
 
 
Minority Interest-69.0K-96.0K-261.0K0.00
 
 
 
 
Discontinued Operations-158.0K0.000.000.00
 
 
Net Income-3.7M-1.7M-2.5M-3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS295.3K395.9K76.1K14.8M
 
 
 
 
 
Shares To Calculate EPS Diluted295.3K395.9K76.1K14.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$12.60-$4.20---$0.27
 
 
 
 
EPS Diluted-$12.60-$4.20-$33.00-$0.27